AIMC Topic: Procalcitonin

Clear Filters Showing 1 to 10 of 16 articles

Development of a risk prediction model for secondary infection in severe/critical COVID-19 patients.

BMC infectious diseases
OBJECTIVE: This study aimed to develop a predictive model for secondary infections in patients with severe or critical COVID-19 by analyzing clinical characteristics and laboratory indicators.

High procalcitonin level is related to blood stream infections, gram-negative pathogens, and ICU admission in infections of adult febrile cancer patients.

Journal of the Egyptian National Cancer Institute
BACKGROUND: Blood stream infection (BSI) represent a life-threatening condition. Thus, we aimed to investigate the role of procalcitonin (PCT) and C-reactive protein (CRP) tests in adult febrile patients with BSI and other clinical infections in hosp...

Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics.

International journal of molecular sciences
The COVID-19 pandemic has accelerated advances in molecular biology and virology, enabling the identification of key biomarkers to differentiate between severe and mild cases. Furthermore, the use of artificial intelligence (AI) and machine learning ...

Kernel representation-based End-to-End network-enabled decoding strategy for precise and medical diagnosis.

Journal of hazardous materials
Artificial intelligence-assisted imaging biosensors have attracted increasing attention due to their flexibility, allowing for the digital image analysis and quantification of biomarkers. While deep learning methods have led to advancements in biomar...

Association between serum endocan levels and organ failure in hospitalized patients with cirrhosis.

PloS one
BACKGROUND & AIMS: Acute-on-chronic liver failure is a syndrome characterized by organ failure and high short-term mortality. The lack of reliable biomarkers for the early detection of acute-on-chronic liver failure is a significant challenge. Endoth...

Using random forest and biomarkers for differentiating COVID-19 and Mycoplasma pneumoniae infections.

Scientific reports
The COVID-19 pandemic has underscored the critical need for precise diagnostic methods to distinguish between similar respiratory infections, such as COVID-19 and Mycoplasma pneumoniae (MP). Identifying key biomarkers and utilizing machine learning t...

Random forest differentiation of Escherichia coli in elderly sepsis using biomarkers and infectious sites.

Scientific reports
This study addresses the challenge of accurately diagnosing sepsis subtypes in elderly patients, particularly distinguishing between Escherichia coli (E. coli) and non-E. coli infections. Utilizing machine learning, we conducted a retrospective analy...

[Relevant biomarkers in infectiology].

Deutsche medizinische Wochenschrift (1946)
A biomarker in infectiology should ideally be able to identify infectious agents, monitor clinical response and determine the duration of treatment. This article answers the question to what extent C-reactive protein and procalcitonin meet these requ...

Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study.

Journal of medical Internet research
BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination.

Quantum dot modified interface for electrochemical immunosensing of procalcitonin for the detection of urinary tract infection.

Analytica chimica acta
An electrochemical immunoelectrode is fabricated and investigated for quantification of the Procalcitonin (PCT), a protein over expressed in urinary tract infection (UTI). The sensor electrode is prepared by self assembling the conjugate of Zinc sulf...